MedDataX Logo

Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors

NCT ID: NCT03293251

Last Updated: 2017-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-01

Study Completion Date

2018-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. determine whether cataract surgery has a major effect on outcomes of trabeculectomy with MMC or not.
2. Success rates of trabeculectomy with MMC in Queen Elizabeth hospital.
3. recurrence rate of uveitis after glaucoma surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. determine different success rates of trabeculectomy with MMC undergone in QE hospital, UK.
2. determine different complications and effect of cataract surgery on the outcome of glaucoma surgery

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Outcomes of Trabeculectomy With MMC

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

uveitic/ POAG

Outcomes, success rates, complications of trabeculectomy with MMC in Uveitic glaucoma

Trabeculectomy with MMC

Intervention Type PROCEDURE

glaucoma surgeries

POAG

Outcomes, success rates, complications of trabeculectomy with MMC and I stent in this groups

Trabeculectomy with MMC

Intervention Type PROCEDURE

glaucoma surgeries

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trabeculectomy with MMC

glaucoma surgeries

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

I-STENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Fesh trabeculectomy surgeries

Exclusion Criteria

* recurrent surgeries
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Queen Elizabeth Hospital

OTHER

Sponsor Role collaborator

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maha omar mahmoud said

principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr Kamel Soliman, professor

Role: STUDY_DIRECTOR

Assiut University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maha Said

Egypt, Asyut Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1111

Identifier Type: -

Identifier Source: org_study_id